Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis

← catalyst calendar

NCT02675114 · results posted

Sponsored by Edwards Lifesciences (industry) · EW — their whole pipeline →.

Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
1,000actual
Sites
77
Countries
Australia, Canada, Japan +2

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
StartMar 2016actualWhen the study began enrolling
Primary completion2020-11-16actualThe date the last participant is measured for the primary outcome — the readout window
Study completionDec 2029estimatedThe whole study's end, after follow-up
First posted2016-02-05estimatedWhen this record first appeared on the registry
Results posted2021-12-02actualWhen the sponsor posted results to the registry
Record updated2026-01-14actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Aortic Stenosis

Interventions

  • Procedure: SAVR
  • Device: SAPIEN 3 THV

Primary outcome

what the primary-completion date above is the date OF
All-cause Mortality, All Stroke, and Rehospitalization (Valve-related or Procedure-related and Including Heart Failure)
measured 1 year

Posted documents

hosted by the registry — we link, never re-serve
Study Protocol and Statistical Analysis Planposted 2018-12-01 · 19.3 MB · Prot_SAP_000.pdf

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · EW's whole pipeline · Catalyst calendar · Every registered study · What changed